Factors influencing participation among melanoma screening attenders

Acta Dermato-Venereologica

Volumn 77, Issue 6, 1997, Pages 467-470

  De Rooij, Michette J M ^a   Rampen, Frans H J ^b   Schouten, Leo J ^c,d   Neumann, H A Martino ^e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Dermatology   (Netherlands)

^c Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

^d Integraal Kankercentrum Oost   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gender; Prevention; Public campaign; Skin cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MASS MEDIUM; MELANOMA; MOTIVATION; NETHERLANDS; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; ATTITUDE TO HEALTH; FEMALE; HEALTH EDUCATION; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS;

EID: 0030736724     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Graham-Brown RAC, Osborne JE, London SP, Fletcher A, Shaw H, Williams B, et al. The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br J Dermatol 1990; 122: 53-59.
2. MacKie RM. Public and professional educational exercises on melanoma. Clin Dermatol 1992; 10: 91-96.
3. Koh HK, Miller DR, Geller AC, Lew RA, Rampen FHJ. Screening for melanoma and other skin cancers. Clin Dermatol 1992; 10: 97-103.
4. Elwood JM. Screening for melanoma and options for its evaluation. J Med Screening 1994; 1: 22-38.
5. de Rooij MJM, Rampen FHJ, Schouten LJ, Neumann HAM. Skin cancer screening focusing on melanoma yields more selective attendance. Arch Dermatol 1995; 131: 422-425.
6. Rampen FHJ, van Huystee BEWL, Kiemeney LALM. Melanoma/skin cancer screening clinics: Experiences in the Netherlands. J Am Acad Dermatol 1991; 25: 776-777.
7. Rampen FHJ, van Huystee BEWL, Kiemeney LALM. Practical considerations of melanoma skin cancer screening clinics. Dermatology 1992; 184: 190-193.
8. Nelemans PJ, Rampen FHJ. The epidemiology of cutaneous melanoma in the Netherlands: A descriptive study. Ned Tijdschr Geneeskd 1990; 134: 2038-2042.
9. Field SI. Melanoma skin cancer screening in Michigan. J Am Acad Dermatol 1987; 16: 578-583.
10. Olsen TG, Feeser TA, Conte ET, Schroeter AL. Skin cancer screening: A local experience. J Am Acad Dermatol 1987; 16: 637-641.
11. Bolognia JL, Berwick M, Fine JA. Complete follow-up and evaluation of a skin cancer screening in Connecticut. J Am Acad Dermatol 1990; 23: 1098-1106.
12. Koh HK, Geller AC, Miller DR, Caruso A, Gage J, Lew RA. Who is being screened for melanoma skin cancer? Characteristics of persons screened in Massachusetts. J Am Acad Dermatol 1991; 24: 271-277.
13. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who discovers melanoma? J Am Acad Dermatol 1992; 26: 914-919.
14. Melia J, Ellman R, Chamberlain J. Investigating changes in awareness about cutaneous malignant melanoma in Britain using the Omnibus Survey. Clin Exp Dermatol 1994; 19: 375-379.
15. Shaw HM, McGovern VJ, Milton GW, Farago GA, McCarthy WH. Malignant melanoma: Influence of site of lesion and age of patient in the female superiority in survival. Cancer 1980; 46: 2731-2735.
16. Rampen FHJ. Sex differences in survival from cutaneous melanoma. Int J Dermatol 1984; 23: 444-452.
17. Vossaert KA, Silverman MK, Kopf AW, Bart RS, Rigel DS, Friedman RJ, et al. Influence of gender on survival in patients with stage I malignant melanoma. J Am Acad Dermatol 1992; 26: 429-440.
18. MacKie RM, Hole DJ. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 1992; 304: 1012-1015.
19. Girasek DC. Motivating the public to take advantage of skin cancer screening. J Am Acad Dermatol 1986; 15: 309-315.
20. Brandberg Y, Bolund C, Michelson H, Mansson-Brahme E, Ringborg U, Sjödén PO. Psychological reactions in public melanoma screening. Eur J Cancer 1993; 29A: 860-863.
21. Rigel DS, Friedman RJ, Kopf AW, et al. Importance of complete cutaneous examination for detection of malignant melanoma. J Am Acad Dermatol 1986; 14: 857-860.
22. Koh HK, Caruso A, Gage I, et al. Evaluation of melanoma skin cancer screening in Massachusetts. Cancer 1990; 65: 375-379.
23. Newman S, Nichols S, Freer C, Izzard L. How much do the public know about moles, skin cancer and malignant melanoma? The results of a postal survey. Community Med 1988; 10: 351-357.
24. Polednak AP. Malignant melanoma of the skin in upstate New York: Recent trends and characteristics. Cancer Detect Prevent 1985; 8: 485-495.